What is TruMed Systems?
TruMed Systems is recognized as the fastest-growing provider of advanced vaccine storage and handling solutions. Their offerings cater to individual clinics, large health systems, and public healthcare facilities throughout the United States. The flagship AccuVax system automates vaccine control and integrity, mitigating the risks associated with incorrect vaccine delivery and streamlining office operations to allow healthcare professionals to focus on patient care. Complementing this, AccuShelf extends TruMed's inventory management capabilities to encompass all medications within a healthcare environment. All TruMed products integrate hardware, software, online reporting, ongoing software updates, comprehensive training, optional EHR integrations, 24/7 support, and robust security measures.
How much funding has TruMed Systems raised?
TruMed Systems has raised a total of $9.1M across 3 funding rounds:
Series A
$3.2M
Series B
$5.5M
Debt
$350K
Series A (2013): $3.2M, investors not publicly disclosed
Series B (2015): $5.5M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Key Investors in TruMed Systems
PPP
Public-Private Partnership
What's next for TruMed Systems?
With a substantial enterprise-level funding context and a recent strategic investment, TruMed Systems is poised for accelerated growth and market expansion. The company's focus on automating critical aspects of vaccine and medication management positions it to capitalize on the increasing demand for efficient and secure healthcare supply chain solutions. Future developments are likely to involve further integration of their AccuVax and AccuShelf systems, potentially expanding into new therapeutic areas or geographical markets. The strategic nature of the recent financing suggests a focus on enhancing market penetration and solidifying its competitive advantage in the healthcare technology sector.
See full TruMed Systems company page
